These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10279339)

  • 1. Biotechnology: the view from the FDA.
    Young FE
    Health Matrix; 1986; 4(3):10-5. PubMed ID: 10279339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drug approval process at the Food and Drug Administration. New biotechnology as a paradigm of a science-based activist approach.
    Miller HI; Young FE
    Arch Intern Med; 1989 Mar; 149(3):655-7. PubMed ID: 2645844
    [No Abstract]   [Full Text] [Related]  

  • 3. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agency perspectives on food safety for the products of animal biotechnology.
    Howard HJ; Jones KM; Rudenko L
    Reprod Domest Anim; 2012 Aug; 47 Suppl 4():127-33. PubMed ID: 22827361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
    Krimsky S
    Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of molecular techniques in bioremediation.
    Płaza G; Ulfig K; Hazen TC; Brigmon RL
    Acta Microbiol Pol; 2001; 50(3-4):205-18. PubMed ID: 11930989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public information and the ethical responsibility of the industry.
    Bieri F
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):491-6. PubMed ID: 7885074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA's cloning report bypasses ethics, exposes European dilemma.
    Vermij P
    Nat Biotechnol; 2007 Jan; 25(1):7-8. PubMed ID: 17211377
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulating recombinant DNA biologics.
    Crouch ML
    Arzneimittelforschung; 1988 Jul; 38(7):947-9. PubMed ID: 3207440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.
    Zineh I; Pacanowski MA
    Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology: can a new technology survive?
    Withers WW; Kenworthy PG
    St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845
    [No Abstract]   [Full Text] [Related]  

  • 17. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food and agricultural biotechnology: a summary and analysis of ethical concerns.
    Thompson PB; Hannah W
    Adv Biochem Eng Biotechnol; 2008; 111():229-64. PubMed ID: 18496654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotechnology: an introduction to recombinant DNA technology and product availability.
    Evens RP; Witcher M
    Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. After Dolly--ethical limits to the use of biotechnology on farm animals.
    Lassen J; Gjerris M; Sandøe P
    Theriogenology; 2006 Mar; 65(5):992-1004. PubMed ID: 16253321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.